LOAd703, an Oncolytic Virus–Based Immunostimulatory Gene Therapy, Plus Chemotherapy for Unresectable or Metastatic Pancreatic Cancer prac.co/l/2coje2tk via PracticeUpdate

CG Oncology is the first biotechnology company to complete an IPO in 2024, raising US$380 million through its IPO in January this year. The company's oncolytic viral therapy, cretostimogene, is currently being tested in three clinical trials.

The novel investigational oncolytic immunotherapy cretostimogene grenadenorepvec elicited durable CRs over 12 months in patients with high-risk BCG-unresponsive NMIBC with carcinoma in situ. @mayoclinic Amer. Urol. Assn. #AUA24 #oncology onclive.com/view/cretostim…

New #JITC article: Targeting NKG2D ligands in glioblastoma with a bispecific T-cell engager is augmented with conventional therapy and enhances oncolytic virotherapy of glioma stem-like cells bit.ly/4aguLrN Richard Baugh Peter Wan

Joseph Mazar, PhD presents 'The Oncolytic Activity of Zika Viral Therapy Confers a Dramatic Survival Advantage in High-Risk Neuroblastoma in Vivo Models' at our Pediatric Academic Societies Booth (#717)! Join us at 4pm! #PAS2024 #NemoursChildrens #WellBeyondMedicine bit.ly/4b6N3wg

NMIBC | MIBC | Mechanism of Action of CG0070 | CG Oncology #oncolytic $CADL cgoncology.com/science/

Novel Oncolytic Immunotherapy Yields Enduring Responses in High-Risk NMIBC cancernetwork.com/view/novel-onc… via @CancerNetwork®

AstraZeneca scraps Transgene pact in blow to oncolytic viruses #ouch fiercebiotech.com/biotech/astraz…

『An oncolytic virus delivering tumor-irrelevant bystander T cell epitopes induces anti-tumor immunity and potentiates cancer immunotherapy』
Nature Cancer 12 April 2024

SARS-CoV-2特異的T細胞記憶を標的としたOV-BYTEはヒト腫瘍細胞由来ゼノグラフトモデルで腫瘍進展を抑制しました

$CADL added some. Why is this stock still so far away from 1B market cap line? Very unique oncolytic platform with positive phase II survival data at hand. Waiting for secondary offering?

Medicilon and Binhui Biopharmaceutical (Binui Bio) announced a strategic collaboration in cutting-edge fields such as oncolytic viruses, nucleic acid drugs and protein drugs. #nucleicacid #oncolyticviruses
medicilon.com/our-events/bin…

Oncolytics Bio's cancer-killing virus arms CAR-T cells to attack solid tumors in mice | Fierce Biotech #oncolytic fiercebiotech.com/research/oncol…

Delighted to share our new manuscript published this week in @JITC showcasing a novel oncolytic herpes simplex virus armed to express a Bi-specific T cell Engager which targets NKG2D ligands in glioblastoma.

Seymour Lab Oxford
OxfordOncology
Brain Research UK

Oncolytic Viruses: A Promising New Option in Cancer Treatment targetedonc.com/view/oncolytic… via @targetedonc

New #clinicaltrial will examine a novel oncolytic virus called MEM-288 in combination w the immunotherapy agent, Opdivo (nivolumab), in #lungcancer Moffitt Cancer Center. Aim to determine ORR of MEM-288 + Opdivo

Those w EGFR or ALK must have been treated w a TKI.
curetoday.com/view/oncolytic…

Congratulations to CG Oncology, Inc. on the impressive results from their Phase 3 BOND-003 trial of cretostimogene. A 75.2% complete response rate in BCG-unresponsive NMIBC is a significant step forward for bladder cancer treatment.

This progress in #oncolytic #immunotherapy aligns…

The novel oncolytic immunotherapy cretostimogene grenadenorepvec induced complete responses in three-fourths of patients with BCG-unresponsive non–muscle-invasive #bladdercancer with carcinoma in situ , according to findings from the phase 3 BOND-003 trial auajournals.org/doi/abs/10.109…

Merck ditches Cavatak more than 4 years after buying Viralytics … tjs en course avec Tilt et Oncolytics fiercebiotech.com/biotech/merck-…